Thought Leadership
Investors are removing money from biotech funds, are being lukewarm on IPOs, and have been doubtful of some startups – but why?
For early-round startups, attracting and hiring exceptional executive talent is required. Yet, partnering with an external agency may not be financially viable. Enter LifeSci Search Accelerate!
From our vantage point, many biotech and biopharma firms struggling with talent attraction and retention have three commonalities. Discover what they are—but more importantly—what you can do.
CHROs and other relative roles such as CPOs deserve a spot on your Board – particularly given the immense focus on talent attraction and retention currently.
Psychedelics have explosive potential in the mental health space, but strong market optimism is balanced by institutional wariness – and even bias.
Nvidia’s new Hopper 100 GPU represents a massive, industry-changing leap forward for drug discovery powered by machine learning.
Are Special Purpose Acquisition Companies (SPACs) here to stay? Paul Cashman shares his thoughts plus when to use them.
More than ever, companies are having to adapt quickly to attract and retain talent. One area is age-inclusive leadership. Learn more!
Jennifer Phillips provides a comprehensive breakdown of a potential cancer vaccine, and the role biotech has in its development.
Learn more about the science behind human motivation and how this can provide a roadmap for managers in driving meaningful employee engagement.